Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Core Insights - Inspira Technologies has engaged a leading consulting firm to enhance strategic expansion, partner engagement, and advanced structuring pathways [1][4] - The consulting firm specializes in assisting biotech and medtech companies at critical inflection points, focusing on high-value strategic transactions and commercial growth [2] - Recent developments include major purchase orders, national-level strategic frameworks with government health authorities, and clinical integration of the ART100 system in Tier-1 U.S. hospitals, positioning the company for commercial scaling [3] Company Overview - Inspira Technologies is a commercial-stage medical device company specializing in advanced respiratory support and real-time blood monitoring solutions [5] - The INSPIRA™ ART100 system is FDA-cleared for cardiopulmonary bypass in the U.S. and ECMO procedures outside the U.S., with plans for the next-generation INSPIRA ART500 system [5] - The company is also advancing the HYLA™ blood sensor platform for continuous, non-invasive monitoring, and is positioned as an attractive platform within the life-support and MedTech landscape [5]